Moudouni S M, Latabi A, Mouaad A, Lakmichi M A, Dahami Z, Sarf I
Centre hospitalier universitaire de Marrakech, Marrakech, Maroc.
Centre hospitalier universitaire de Marrakech, Marrakech, Maroc.
Prog Urol. 2019 Jan;29(1):50-62. doi: 10.1016/j.purol.2018.09.001. Epub 2018 Dec 20.
The objective of this work was to evaluate the impact of the laparoscopic radical cystectomy learning curve on perioperative and oncological outcomes.
This is a retrospective and single-center study of all patients who underwent laparoscopic radical cystectomy for bladder cancer from February 2007 to March 2016, (93 patients) Perioperative and oncological data were collected. We used mixed statistical models to predict the number of patients needed in the learning phase. We compared the perioperative parameters of the patients in the learning phase with those of the rest of the patients. Overall survival was estimated using the Kaplan-Meier method.
Thirty-six patients are required for the learning phase (P1). The expertise phase begins after the 36th LRC (P2). In both phases, there was no significant difference in age, ASA score, and tumor stage (P=0.237, P=0.577, P=0.998). Mean operative time was 328.3min and 262.4min in P1 and P2 (P=0.0001), mean blood loss was 333.7mL and 194.3mL in P1 and P2 respectively (P=0.0003). The rate of major complications was high in the learning phase (P=0.042). There was no significant difference in lymph node yield, positive surgical margins and overall survival (P=0.068, P=0.194, P=0.703).
This learning experience was evaluated without compromising oncological results, but with a significantly higher rate of major complications.
本研究的目的是评估腹腔镜根治性膀胱切除术学习曲线对围手术期和肿瘤学结果的影响。
这是一项对2007年2月至2016年3月期间所有接受腹腔镜根治性膀胱切除术治疗膀胱癌的患者进行的回顾性单中心研究(93例患者)。收集围手术期和肿瘤学数据。我们使用混合统计模型预测学习阶段所需的患者数量。我们比较了学习阶段患者与其他患者的围手术期参数。采用Kaplan-Meier法估计总生存率。
学习阶段(P1)需要36例患者。专业阶段在第36例腹腔镜根治性膀胱切除术后开始(P2)。在两个阶段,年龄、美国麻醉医师协会(ASA)评分和肿瘤分期均无显著差异(P=0.237,P=0.577,P=0.998)。P1和P2阶段的平均手术时间分别为328.3分钟和262.4分钟(P=0.0001),P1和P2阶段的平均失血量分别为333.7毫升和194.3毫升(P=0.0003)。学习阶段的主要并发症发生率较高(P=0.042)。淋巴结获取数量、手术切缘阳性率和总生存率无显著差异(P=0.068,P=0.194,P=0.703)。
本次学习经验在不影响肿瘤学结果的情况下进行了评估,但主要并发症发生率明显更高。
3级。